Generate Biomedicines Inc（GENB）の株価予測

$15.330

-0.428 (-2.79%)終値時点

価格予想

1-Day Price Prediction

-1.79%

1-Week Prediction

-0.28%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

アプリで開くと、より長期の予想を確認できます。

Loading chart…

類似チャート分析による GENB の予測・予想

Alphio's GENB stock price prediction model matches the current Generate Biomedicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.06 (-1.79%). The 1-week path is $15.29 (-0.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Generate Biomedicines Inc 株は買うべき？

Generate Biomedicines, Inc. is currently not a strong buy due to declining revenues and increasing net losses, despite a promising pipeline. The stock closed at $15.33, and the RSI is at 42.164, indicating a neutral momentum. The forward P/E is currently at 0, reflecting uncertainty in earnings growth. The main risk is the significant net loss of $67.3 million reported for Q2 2026, which raises concerns about liquidity and operational sustainability.